Viral hepatitis B
Top Cited Papers
- 1 December 2003
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 362 (9401) , 2089-2094
- https://doi.org/10.1016/s0140-6736(03)15108-2
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- A randomised double-blind phase II study of lamivudine (LAM) compared to lamivudine plus adefovir dipovoxil (ADV) for treatment naïve patients with chronic hepatitis B (CHB): Week 52 analysisJournal of Hepatology, 2003
- Prognostic Factors in Severe Exacerbation of Chronic Hepatitis BClinical Infectious Diseases, 2003
- Significance of Hepatitis B Genotype in Acute Exacerbation, Hbeag Seroconversion, Cirrhosis–Related Complications, and Hepatocellular CarcinomaHepatology, 2003
- An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individualsAIDS, 2003
- Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infectionHepatology, 2002
- Relationship between the Development of Precore and Core Promoter Mutations and Hepatitis B e Antigen Seroconversion in Patients with Chronic Hepatitis B VirusThe Journal of Infectious Diseases, 2002
- Antiviral l -Nucleosides Specific for Hepatitis B Virus InfectionAntimicrobial Agents and Chemotherapy, 2001
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- Viral Clearance Without Destruction of Infected Cells During Acute HBV InfectionScience, 1999
- Identification and characterization of mutations in hepatitis B virus resistant to lamivudineHepatology, 1998